1. Home
  2. CCNE vs TYRA Comparison

CCNE vs TYRA Comparison

Compare CCNE & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCNE
  • TYRA
  • Stock Information
  • Founded
  • CCNE 1865
  • TYRA 2018
  • Country
  • CCNE United States
  • TYRA United States
  • Employees
  • CCNE N/A
  • TYRA N/A
  • Industry
  • CCNE Major Banks
  • TYRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCNE Finance
  • TYRA Health Care
  • Exchange
  • CCNE Nasdaq
  • TYRA Nasdaq
  • Market Cap
  • CCNE 523.6M
  • TYRA 422.6M
  • IPO Year
  • CCNE N/A
  • TYRA 2021
  • Fundamental
  • Price
  • CCNE $21.37
  • TYRA $8.92
  • Analyst Decision
  • CCNE Hold
  • TYRA Strong Buy
  • Analyst Count
  • CCNE 1
  • TYRA 6
  • Target Price
  • CCNE $25.00
  • TYRA $30.50
  • AVG Volume (30 Days)
  • CCNE 93.8K
  • TYRA 353.6K
  • Earning Date
  • CCNE 04-14-2025
  • TYRA 05-08-2025
  • Dividend Yield
  • CCNE 3.37%
  • TYRA N/A
  • EPS Growth
  • CCNE N/A
  • TYRA N/A
  • EPS
  • CCNE 2.34
  • TYRA N/A
  • Revenue
  • CCNE $219,886,000.00
  • TYRA N/A
  • Revenue This Year
  • CCNE $11.04
  • TYRA N/A
  • Revenue Next Year
  • CCNE $30.14
  • TYRA N/A
  • P/E Ratio
  • CCNE $9.14
  • TYRA N/A
  • Revenue Growth
  • CCNE 1.97
  • TYRA N/A
  • 52 Week Low
  • CCNE $17.74
  • TYRA $6.42
  • 52 Week High
  • CCNE $29.29
  • TYRA $29.60
  • Technical
  • Relative Strength Index (RSI)
  • CCNE 44.37
  • TYRA 45.95
  • Support Level
  • CCNE $19.78
  • TYRA $8.23
  • Resistance Level
  • CCNE $21.66
  • TYRA $8.80
  • Average True Range (ATR)
  • CCNE 1.17
  • TYRA 0.70
  • MACD
  • CCNE 0.09
  • TYRA 0.19
  • Stochastic Oscillator
  • CCNE 64.06
  • TYRA 75.30

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. In addition, the corporation provides wealth and asset management services, retirement plans and other employee benefit plans.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: